Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetic acid, glacial 💬1件: Acetic acid1件: Acetic acid--3件: 21, 97, 296 💬
2 Acetylcysteine 💬1件: Acetylcysteine4件: ACETYLCYSTEINE; N acetyl cysteine; N-acetyl cysteine; N-acetylcysteine--25件: 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
3 Ammonia solution, strong 💬1件: Ammonia1件: Ammonia--6件: 6, 17, 86, 88, 251, 296 💬
4 Belimumab 💬1件: Belimumab1件: BELIMUMAB1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬17件: 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
5 Bezafibrate 💬1件: Bezafibrate1件: Bezafibrate1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
6 Cefaclor 💬1件: Cefaclor1件: Cefaclor--1件: 296 💬
7 Cefaclor 💬1件: Cefaclor1件: Cefaclor--1件: 296 💬
8 Cefoperazone 💬1件: Cefoperazone1件: Cefoperazone--1件: 296 💬
9 Cefoperazone sodium 💬1件: Cefoperazone1件: Cefoperazone--1件: 296 💬
10 Cysteine hydrochloride 💬1件: Cysteine2件: Cysteine; Cysteine hydrochloride--13件: 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
11 Desflurane 💬1件: Desflurane1件: Desflurane--2件: 22, 296 💬
12 Dexamethasone 💬1件: Dexamethasone4件: Dexametasone; Dexamethason; Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
13 Dexamethasone phosphate 💬1件: Dexamethasone4件: Dexametasone; Dexamethason; Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
14 Dexamethasone sodium phosphate 💬1件: Dexamethasone4件: Dexametasone; Dexamethason; DEXAMETHASONE; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
15 Dimethyl fumarate 💬1件: Dimethyl fumarate1件: Dimethyl fumarate1件: KEAP1 💬 6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬5件: 13, 20, 51, 86, 296 💬
16 Filgrastim 💬1件: Filgrastim4件: Filgrastim; G-CSF; Gcsf; GRANULOCYTE COLONY STIMULATING FACTOR1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬30件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
17 Folate sodium 💬1件: Folic acid4件: Acide folique; Folacin; Folate; Folic acid--9件: 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
18 Folic acid 💬1件: Folic acid4件: Acide folique; Folacin; Folate; Folic Acid--9件: 6, 46, 49, 50, 84, 97, 118, 172, 296 💬
19 Imipenem 💬1件: Imipenem1件: Imipenem--3件: 60, 296, 299 💬
20 Imipenem 💬1件: Imipenem1件: Imipenem--3件: 60, 296, 299 💬
21 Indocyanine green 💬1件: Indocyanine green acid form1件: Indocyanine green--9件: 22, 41, 46, 51, 96, 235, 278, 291, 296 💬
22 L-Cysteine 💬1件: Cysteine2件: Cysteine; Cysteine hydrochloride--13件: 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
23 Lactobacillus casei 💬1件: Lactobacillus casei1件: Lactobacillus casei--3件: 6, 97, 296 💬
24 Magnesium gluconate 💬1件: Magnesium gluconate2件: Magnesium; Magnesium gluconate--2件: 296, 297 💬
25 Magnesium sulfate 💬1件: Magnesium sulfate2件: Magnesium sulfate; MAGNESIUM SULFATE HEPTAHYDRATE--4件: 11, 97, 296, 297 💬
26 Maralixibat 💬1件: Maralixibat2件: Maralixibat; MARALIXIBAT CHLORIDE2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬4件: 296, 297, 299, 338 💬
27 Maralixibat chloride 💬1件: Maralixibat2件: Maralixibat; MARALIXIBAT CHLORIDE1件: SLC10A2 💬 1件: Bile secretion 💬4件: 296, 297, 299, 338 💬
28 Meloxicam 💬1件: Meloxicam1件: Meloxicam1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 49, 271, 296 💬
29 Meropenem 💬1件: Meropenem2件: Meropenem; MEROPENEM TRIHYDRATE--3件: 60, 296, 299 💬
30 Meropenem 💬1件: Meropenem2件: Meropenem; MEROPENEM TRIHYDRATE--3件: 60, 296, 299 💬
31 Methylprednisolone 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
32 Methylprednisolone acetate 💬1件: Methylprednisolone3件: Methylprednisolon; Methylprednisolone; Methylprednisolone acetate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
33 Neomycin 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
34 Neomycin palmitate 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
35 Neomycin sulfate 💬1件: Neomycin1件: Neomycin--3件: 96, 97, 296 💬
36 Noradrenaline 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine Bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
37 Norepinephrine bitartrate 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine Bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
38 Norepinephrine hydrochoride 💬1件: Norepinephrine2件: Norepinephrine; Norepinephrine Bitartrate9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
39 Obeticholic acid 💬1件: Obeticholic acid1件: Obeticholic Acid1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
40 Odevixibat 💬1件: Odevixibat1件: Odevixibat1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
41 Odevixibat hydrate 💬1件: Odevixibat1件: Odevixibat1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
42 Pentoxifylline 💬1件: Pentoxifylline1件: Pentoxifylline--13件: 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
43 Prednisolone 💬1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
44 Propofol 💬1件: Propofol1件: PROPOFOL16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
45 Rifaximin 💬1件: Rifaximin2件: Rifaximin; RIFAXIMINA--8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
46 Rituximab 💬1件: Rituximab1件: Rituximab1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
47 Rocuronium bromide 💬1件: Rocuronium2件: Rocuronium; Rocuronium Bromide16件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬 		16件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 70, 296 💬
48 Sevoflurane 💬1件: Sevoflurane1件: Sevoflurane--8件: 6, 21, 22, 34, 70, 98, 225, 296 💬
49 Sulfamethoxazole 💬1件: Sulfamethoxazole2件: Sulfamethoxazole; Sulphamethoxazole--8件: 35, 44, 49, 61, 85, 223, 296, 299 💬
50 Ursodiol 💬1件: Ursodeoxycholic acid3件: UDCA; Ursodeoxycholic Acid; Ursodiol1件: NR1H4 💬 1件: Bile secretion 💬10件: 6, 46, 67, 84, 93, 94, 95, 96, 97, 296 💬
51 Vancomycin 💬1件: Vancomycin1件: Vancomycin--9件: 6, 13, 46, 70, 94, 96, 97, 296, 299 💬
52 Vancomycin hydrochloride 💬1件: Vancomycin1件: Vancomycin--9件: 6, 13, 46, 70, 94, 96, 97, 296, 299 💬